Immune biomarkers in circulating cells of NSCLC patients can effectively evaluate the efficacy of chemotherapy combined with anti-PD-1 therapy by Jing Cao, Yuehua Zhang, Shenghu Guo, Zheng Wu, Xiaojin Guo, Rongze Zhang, Lei Zhang, Ya Liu, Xing Li, Chunwang Yang, Dongwei He, Lu Bai, Tingting Lv, Yong Xie, Chengjing Huang, Shuang Xiao, Anyi Deng, Jiawei Li, Jiawei Li, Jiaxing Zhu, Zhenghu Jia, Zhenghu Jia, Zhinan Yin, Zhiyu Wang

Get full text